Objectives: The objective of this study was to clarify the characteristic brain MRI findings for genetically diagnosed CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).
the case notes. The Niigata University institutional review board approved this study. We obtained informed consent from all subjects or their families.
Imaging analysis. All patients underwent axial T1-weighted, T2-weighted, and fluid-attenuated inversion recovery imaging of the brain. The MRIs were obtained using a 1.0-or 1.5-tesla multicenter system. Longitudinal MRI studies were performed for 5 of the 7 patients. We developed a scale for evaluating the severity of abnormal hyperintense lesions and atrophy of the brain on MRI by modifying the Scheltens rating scale (table e-1 on the Neurology ® Web site at Neurology.org). 8 The interrater reliability evaluated by intraclass correlation coefficient was high (r 5 0.89; 95% confidence interval, 0.73-0.96). Two neurologists reviewed the findings from 18 brain MRIs of the 7 patients in a blinded fashion. All statistical analyses were performed with SPSS Statistics version 22 (IBM, Armonk, NY).
RESULTS Characteristic MRI features of CARASIL.
Representative brain MRI findings are shown in figure 1 , and the distributions of abnormal hyperintense lesions on T2-weighted images at the last follow-up are described in table e-2. At the last follow-up, all patients had hyperintense lesions, predominantly in the frontal white matter and the anterior temporal lobe (figure 1, A, B, E, F, I, and J). The lesions diffusely extended from the periventricular to the juxtacortical region, with small cavities and relatively spared U fibers. At the basal ganglia, all patients had hyperintense lesions in the external capsules as linear foci and in the thalami as multiple foci ( figure 1, B , G, and H). Six of the 7 patients had hyperintense lesions in the internal capsules. In the infratentorial region, 6 of 7 patients had abnormal linear high-intensity lesions in the cerebral peduncles of the midbrain, and 5 patients had arc-shaped lesions from the pons to the middle cerebellar peduncles (figure 1, K and L). We obtained susceptibility-weighted images for one patient and T2* gradient echo images for 2 patients and found multiple microbleeds in the cerebral cortex and white matter in 2 patients ( figure 1D , table e-2). Brain atrophy was predominant in the central white matter, with dilation of the lateral ventricle ( figure 1A ).
Cervical and lumbar MRIs were obtained for 3 patients; these showed severe degeneration of disks and vertebrae with canal stenosis (figure e-1). These findings were observed from C3 to C7 on cervical spines and from L1 to L5 on lumbar spines, ranges that are relatively widespread compared with those observed in age-related spondylosis.
Rating system for assessing severity using brain MRI findings for CARASIL. We developed a rating scale to evaluate the severity of brain MRI findings (table e-1). The rating scale has 2 parts: signal score ranging from 0 to 34 and atrophy score ranging from 0 to 21. The total score ranges from 0 to 55. We applied the rating scale for 18 MRIs, including sequential MRIs from 5 patients. We plotted each score and time from the onset of cognitive impairment (figure 2, A-C). The mean disease duration since the age at onset of cognitive impairment was 5.4 years during initial MRI studies (range, 21 to 16 years) and was 10.6 years during the last MRI studies (range, 1-27 years). The mean rates of increase in scores per disease duration were 2.0 (range, 0.8-4.0) for total score, 1.2 (range, 0.4-3.5) for signal score, and 0.9 (range, 0.5-1.5) for atrophy score. During the last followup MRI examination of each patient, patients with longer disease duration had higher total score (r 5 0.955; p , 0.01), signal score (r 5 0.963; p , 0.001), and atrophy score (r 5 0.818; p , 0.05). We plotted the signal score and atrophy score and found that the progression of atrophy was followed by the appearance of abnormal hyperintense lesions ( figure 2D ).
Pattern of progression from brain MRI findings. To investigate the progression of MRI findings, we divided the images into 3 stages based on total scores and enrolled the earliest MRI study for each individual at each stage (early stage ,25; middle stage $25 and ,35; late stage $35) ( figure 3A) . During the early stage, white matter hyperintensity was predominant in the frontal lobe. The signal scores decreased in the following order: frontal, parietal, temporal, occipital. In all cases, hyperintense lesions in the external capsule and pons were observed. During the middle stage, the hyperintense lesions became evident in the putamen, thalamus, internal capsule, and midbrain. During the late stage, infratentorial hyperintense lesions were evident. When evaluating atrophy score, central and brainstem atrophy were found to be predominant during the early stage (figure 3B ). During the middle stage, atrophy was marked in the frontal cortex and temporal cortex. Cerebellar atrophy was evident during the late stage. DISCUSSION We have shown characteristic brain MRI features of CARASIL in patients carrying mutations in the HTRA1 gene. The involvement of the external capsule with frontal dominant white matter lesions is a characteristic feature during the early stage of CARASIL. The MRI findings are not so different from those observed with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 9 During the advanced stage, we found a hyperintense arc-shaped lesion from the pons to the middle cerebellar peduncles. This lesion may represent involvement of the pontocerebellar tract and is a characteristic MRI feature during the advanced stage of CARASIL. We designated it the "arc sign." By using our rating scale for brain MRI findings, we found that disease duration after onset of the cognitive impairment strongly correlates with the total, signal, and atrophy scores. The rating scale is useful for assessment of severity of CARASIL and could be used as an adjunct outcome measure for future CARASIL therapeutic trials. The alteration on brain MRIs starts before the onset of cognitive impairment. When the score reached more than 20, cognitive impairment was evident and brain atrophy had started to progress. The results indicate that we have time to prevent disease progression before the onset of dementia. These MRI findings for CARASIL are consistent with the finding that cerebral white matter lesions precede cortical atrophy and onset of dementia in CADASIL. 10 Although CARASIL had been considered to be restricted to Japan, CARASIL has been reported in other populations. 2, 4, 7 Even if spondylosis deformans or alopecia is not present, patients with lesions in the frontal lobe and external capsule on brain MRI should be considered for genetic testing for CARASIL. In the advanced stage, the existence of the arc sign suggests the diagnosis of CARASIL.
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